(Q41670024)

English

Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth

scientific article published on August 1, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth (English)

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

0 references

carcinoid tumor

1 reference

based on heuristic

inferred from title

cultured tumor cells

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712329

5 November 2022

Courtney M. Townsend

2

object named as

Townsend CM Jr

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

1

object named as

Evers BM

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

author name string

J. R. Upp

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712329

5 November 2022

E. Allen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712329

5 November 2022

S. C. Hurlbut

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712329

5 November 2022

S. W. Kim

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712329

5 November 2022

S. Rajaraman

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712329

5 November 2022

P. Singh

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712329

5 November 2022

J. C. Reubi

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712329

5 November 2022

J. C. Thompson

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712329

5 November 2022

language of work or name

0 references

publication date

1 August 1991

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

full work available at URL

https://api.elsevier.com/content/article/PII:0016508591900045?httpAccept=text/xml

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

https://api.elsevier.com/content/article/PII:0016508591900045?httpAccept=text/plain

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

101

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

303-311

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

describes a project that uses

0 references

Carcinoid apudomas

1

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Carcinoids and carcinoid syndrome

2

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Treatment of the carcinoid tumor and the malignant carcinoid syndrome

4

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Regression of carcinoid tumour with cyproheptadine

5

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Ketanserin versus placebo in carcinoid syndrome. A clinical controlled trial

6

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Somatostatin, anaesthesia, and the carcinoid syndrome. Peri-operative administration of a somatostatin analogue to suppress carcinoid tumour activity.

13

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Successful symptomatic treatment of malignant carcinoid syndrome with the somatostatin analogue SMS 201-995

14

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue

15

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Use of somatostatin analog in management of carcinoid syndrome

16

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor

17

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome

18

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Chemotherapy of metastatic carcinoid and islet cell tumors. A review

19

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Inhibition of pentagastrin-stimulated up-regulation of gastrin receptors and growth of mouse colon tumor in vivo by proglumide, a gastrin receptor antagonist

22

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Hormone-producing gastrointestinal tumors contain a high density of somatostatin receptors

23

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Protein measurement with the Folin phenol reagent

25

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid

26

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Regulation of Pancreastatin Release from a Human Pancreatic Carcinoid Cell Line in Vitro*

29

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Tachykinin production by carcinoid tumours in culture

31

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Carcinoid tumour cells in long-term culture: release of serotonin but not of tachykinins on stimulation with adrenoceptor agonists

32

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Serotonin and histamine production by human carcinoid cells in culture

33

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Transplantable argyrophilic gastric carcinoid of Mastomys natalensis secreting both histamine and serotonin

34

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Release of serotonin from human carcinoid tumor cells in vitro and grown in the anterior eye chamber of the rat

35

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Successful transplantation of a human midgut carcinoid tumour to the anterior eye chamber of the rat

36

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

On the mode of action of the pentagastrin test in the carcinoid syndrome.

37

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Somatostatin and Analogues in the Treatment of Cancer

39

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells

40

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Antiproliferative effects of somatostatin and the somatostatin analog SMS 201-995 on three human breast cancer cell lines

42

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer

43

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995.

44

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growth.

46

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Clinical and hormonal effects of a long-acting somatostatin analogue in pancreatic endocrine tumors and in carcinoid syndrome

48

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Use of a somatostatin analogue in association with surgery and hepatic arterial embolisation in the treatment of the carcinoid syndrome

49

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Chemotherapeutic implications of polyamine biosynthesis inhibition

50

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Heterogeneous survival responses of human gastric cancer clones to alpha difluoromethylornithine in vitro

55

1 reference

10.1016/0016-5085(91)90004-5

https://api.crossref.org/works/10.1016/0016-5085(91)90004-5

5 November 2022

Identifiers

10.1016/0016-5085(91)90004-5

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1712329

5 November 2022

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41670024&oldid=1765360502"